tiprankstipranks
QQQ ETF Update, 11/11/2024 
Market News

QQQ ETF Update, 11/11/2024 

Story Highlights

Here’s a quick look at Invesco QQQ Trust ETF’s performance.

How is QQQ stock faring? The Invesco QQQ ETF is up 2.56% in the past five days and has risen about 26.09% year-to-date.  

Don't Miss Our New Year's Offers:

According to TipRanks’ unique ETF analyst consensus, determined based on a weighted average of its holdings’ analyst ratings, QQQ is a Moderate Buy. The Street’s average price target of $558.83 implies an upside of 8.69%. 

Currently, QQQ’s five holdings with the highest upside potential are Moderna (MRNA), Super Micro Computer (SMCI), Biogen (BIIB), AstraZeneca (AZN), and PDD Holdings (PDD).

Meanwhile, its five holdings with the greatest downside potential are Tesla (TSLA), Old Dominion Freight Line (ODFL), Paychex (PAYX), Fortinet (FTNT), and Intel (INTC).

Revealingly, QQQ ETF has a Smart Score of eight, implying that this ETF is likely to outperform the market. 

Power up your ETF investing with TipRanks. Discover the Top Equity ETFs with High Upside Potential, carefully curated based on TipRanks’ analysis.  

Disclosure  

Related Articles
TheFlyHutchmed announces NDA acceptance in China, payment from AstraZeneca
Joseph E. LeviLevi & Korsinsky LLP Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC(AZN) Shareholders
TipRanks Auto-Generated NewsdeskAstraZeneca Withdraws Lung Cancer Drug Application in EU
Go Ad-Free with Our App